Physician profile
W Randall Russell
NPI 1104823475
$2,657.15
in general payments reported to CMS, 2019-2025
18 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $36.84 · 2021: $250 · 2022: $694 · 2023: $376 · 2024: $96.29 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $848.41 | 2019 | |
| Smith+Nephew, INC. | $617.70 | 2019-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Cashflow Solutions, LLC | $510.73 | 2022-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Resmed Corp | $95.00 | 2022-2023 | |
| Organogenesis INC. | $81.95 | 2020-2021 | |
| Convatec INC. | $70.59 | 2019-2025 | |
| Solventum Corporation | $68.07 | 2024-2025 | Activ.A.C. |
| Kci USA, INC. | $63.19 | 2021-2023 | Activ.A.C., V.A.C. Dermatac |
| Abbvie INC. | $53.22 | 2023-2025 | Dalvance |
| Tactile Systems Technology INC | $51.32 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Hydrofera LLC | $37.75 | 2021 | |
| Next Science LLC | $26.26 | 2023 | Xperience, Blastx, Surgx |
| Medtronic, INC. | $25.96 | 2023 | Intellis Adaptivestim |
| Hartmann USA, INC. | $24.78 | 2023 | Zetuvit Plus |
| Medline Industries LP | $22.35 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $20.51 | 2019 | |
| Paratek Pharmaceuticals, INC. | $19.75 | 2023 | Nuzyra |
| Integra Lifesciences Corporation | $19.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw W Randall Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.